Avi Kogan

Senior Director, New Product Commercialization at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Avi Kogan's Colleagues at Alnylam Pharmaceuticals
Alexa Bacha

Senior Associate Scientist

Contact Alexa Bacha

Amy Burke

Sr. Manager, Clinical Operations

Contact Amy Burke

Elena Klimova

Regional Strategy and Business Analytics, Europe, Japan, Canada, Australia, Associate Director

Contact Elena Klimova

Marta Marco

Executive Assistant. Ethics & Compliance International markets

Contact Marta Marco

Lara Monti

Medical Project Manager

Contact Lara Monti

Tim Horgan

Director, IT Validation & Compliance

Contact Tim Horgan

View All Avi Kogan's Colleagues
Avi Kogan's Contact Details
HQ
(617) 551-8200
Location
Cambridge,Massachusetts,United States
Company
Alnylam Pharmaceuticals
Avi Kogan's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Avi Kogan
Avi Kogan currently works for Alnylam Pharmaceuticals.
Avi Kogan's role at Alnylam Pharmaceuticals is Senior Director, New Product Commercialization.
Avi Kogan's email address is ***@alnylam.com. To view Avi Kogan's full email address, please signup to ConnectPlex.
Avi Kogan works in the SaaS industry.
Avi Kogan's colleagues at Alnylam Pharmaceuticals are Alexa Bacha, Amy Burke, Elena Klimova, Marta Marco, Lara Monti, Tim Horgan, Isabel Dorado and others.
Avi Kogan's phone number is (617) 551-8200
See more information about Avi Kogan